Skip to main content
Top
Published in: Tumor Biology 11/2014

01-11-2014 | Research Article

Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined

Authors: Kewei Jiang, Yi Zhu, Yan Liu, Yingjiang Ye, Qiwei Xie, Xiaodong Yang, Shan Wang

Published in: Tumor Biology | Issue 11/2014

Login to get access

Abstract

Although nodal invasion represents one of the most powerful prognostic indicators in colorectal cancer (CRC), marked heterogeneity exists within stage III patients. Lymph node ratio (LNR) may offer more precise prognostication in stage III CRC. The aim of this study is to investigate the prognostic impact of LNR on survival in stage III CRC patients. We retrospectively reviewed the data of 288 consecutive patients who underwent radical resection for stage III CRC between January 2000 and December 2008 in the Gastrointestinal Surgery Department, Peking University People’s Hospital. The patients were divided into three groups according to LNR quartiles: LNR < 0.167 (n = 72), 0.167 ≤ LNR < 0.562 (n = 140), and LNR ≥ 0.562 (n = 76). The association between overall survival (OS) and disease-free survival (DFS) and 11 variables including age, gender, tumor location, size, grade, histology, tumor (T) stage, number of metastatic LNs, and LNR was analyzed by multivariate analysis. Survival curves were plotted by the Kaplan-Meier method. Both LNR and the number of metastatic LNs were significant prognostic factors for 5-year DFS and OS in stage III CRC patients. LNR was an independent prognostic factor for 5-year OS. LNR remained an independent prognostic factor in patients with fewer than 12 lymph nodes examined. LNR was a potent independent prognostic predictor for OS and DFS in stage III CRC patients, especially for patients with fewer than 12 lymph nodes examined.
Literature
1.
go back to reference Siegel R, Naishadham D, Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2013;63(2):11–30.PubMedCrossRef Siegel R, Naishadham D, Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2013;63(2):11–30.PubMedCrossRef
2.
3.
go back to reference O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–5.PubMedCrossRef O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–5.PubMedCrossRef
4.
go back to reference Greene FL, Page DL, Fleming ID. American joint committee on cancer staging manual. 6th ed. New York: Springer; 2002.CrossRef Greene FL, Page DL, Fleming ID. American joint committee on cancer staging manual. 6th ed. New York: Springer; 2002.CrossRef
5.
go back to reference Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912–9.PubMedCrossRef Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912–9.PubMedCrossRef
6.
go back to reference Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: a systematic review. J Natl Cancer Inst. 2007;99:433–41.PubMedCrossRef Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: a systematic review. J Natl Cancer Inst. 2007;99:433–41.PubMedCrossRef
7.
go back to reference Kim KH, Yang SS, Yoon YS, et al. Validation of the seventh edition the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical center in Korea. Colorectal Dis. 2011;13:220–6.CrossRef Kim KH, Yang SS, Yoon YS, et al. Validation of the seventh edition the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical center in Korea. Colorectal Dis. 2011;13:220–6.CrossRef
8.
go back to reference Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706–12.PubMedCrossRef Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706–12.PubMedCrossRef
9.
go back to reference Sobin L, Gospodarowicz M, Wittekind C. TNM classification of malignant tumors. 7th ed. New York: Wiley; 2009. Sobin L, Gospodarowicz M, Wittekind C. TNM classification of malignant tumors. 7th ed. New York: Wiley; 2009.
10.
go back to reference Polignano F, Henderson N, Alishahi SH, Zito A. Laparoscopic colectomy for cancer and adequate lymphadenectomy. Association between survival and number of lymph nodes. Surg Endosc. 2006;20:996–7.PubMedCrossRef Polignano F, Henderson N, Alishahi SH, Zito A. Laparoscopic colectomy for cancer and adequate lymphadenectomy. Association between survival and number of lymph nodes. Surg Endosc. 2006;20:996–7.PubMedCrossRef
11.
go back to reference Rodriguez Santiago JM, Munoz E, Marti M, et al. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol. 2005;31:59–66.PubMedCrossRef Rodriguez Santiago JM, Munoz E, Marti M, et al. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol. 2005;31:59–66.PubMedCrossRef
12.
go back to reference Voordeckers M, Vinh-Hung V, Van de Steene J, et al. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol. 2004;70:225–30.PubMedCrossRef Voordeckers M, Vinh-Hung V, Van de Steene J, et al. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol. 2004;70:225–30.PubMedCrossRef
13.
go back to reference Okusa T, Nakane Y, Boku T, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. J Surg Gynecol Obstet. 1990;170(6):488–94. Okusa T, Nakane Y, Boku T, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. J Surg Gynecol Obstet. 1990;170(6):488–94.
14.
go back to reference Inoue K, Nakane Y, Liyama H, et al. The superiority of ratio-based lymph-node staging in gastric carcinoma. J Ann Surg Oncol. 2002;9(1):27–34.CrossRef Inoue K, Nakane Y, Liyama H, et al. The superiority of ratio-based lymph-node staging in gastric carcinoma. J Ann Surg Oncol. 2002;9(1):27–34.CrossRef
15.
go back to reference Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. J Ann Surg Oncol. 2002;9(6):775–84.CrossRef Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. J Ann Surg Oncol. 2002;9(6):775–84.CrossRef
16.
go back to reference Berger AC, Watson JC, Ross EA, et al. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. J Am Surg. 2004;70(3):235–40. Berger AC, Watson JC, Ross EA, et al. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. J Am Surg. 2004;70(3):235–40.
17.
go back to reference Rausei S et al. Impact of lymph node ratio on survival of colorectal cancer patients. Int J Surg. 2013;11:95–9.CrossRef Rausei S et al. Impact of lymph node ratio on survival of colorectal cancer patients. Int J Surg. 2013;11:95–9.CrossRef
18.
go back to reference Lee SD, Kim TH, Kim DY, et al. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. J of Cancer Surg. 2012;38:478–83. Lee SD, Kim TH, Kim DY, et al. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. J of Cancer Surg. 2012;38:478–83.
19.
go back to reference Madbouly KM, Abbas KS, Hussein AM, et al. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. J Am Surg. 2013;68(4):166–78. Madbouly KM, Abbas KS, Hussein AM, et al. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. J Am Surg. 2013;68(4):166–78.
20.
go back to reference Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol. 1991;6:325–44.PubMedCrossRef Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol. 1991;6:325–44.PubMedCrossRef
21.
go back to reference Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76:1165–7.PubMedCrossRef Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76:1165–7.PubMedCrossRef
22.
go back to reference Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219–25.PubMedCrossRef Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219–25.PubMedCrossRef
23.
go back to reference Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41:272–9.PubMedCrossRef Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41:272–9.PubMedCrossRef
24.
go back to reference Wright FC, Law CH, Last L, et al. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol. 2003;10:903–9.PubMedCrossRef Wright FC, Law CH, Last L, et al. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol. 2003;10:903–9.PubMedCrossRef
25.
go back to reference Gorog D, Nagy P, Peter A, et al. Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res. 2003;9:180–3.PubMedCrossRef Gorog D, Nagy P, Peter A, et al. Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res. 2003;9:180–3.PubMedCrossRef
26.
go back to reference Horzic M, Kopljar M. Minimum number of lymph nodes that need to be examined for adequate staging of colorectal cancer: factors influencing lymph node harvest. Hepatogastroenterol. 2005;52:86–9. Horzic M, Kopljar M. Minimum number of lymph nodes that need to be examined for adequate staging of colorectal cancer: factors influencing lymph node harvest. Hepatogastroenterol. 2005;52:86–9.
27.
go back to reference Leibl S, Tsybrovskyy O, Denk H. How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum? Virchows Arch. 2003;443:133–8.PubMedCrossRef Leibl S, Tsybrovskyy O, Denk H. How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum? Virchows Arch. 2003;443:133–8.PubMedCrossRef
28.
go back to reference Peschaud F, Benoist S, Julie C, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. J Ann Surg. 2008;248(6):1067–73.CrossRef Peschaud F, Benoist S, Julie C, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. J Ann Surg. 2008;248(6):1067–73.CrossRef
Metadata
Title
Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined
Authors
Kewei Jiang
Yi Zhu
Yan Liu
Yingjiang Ye
Qiwei Xie
Xiaodong Yang
Shan Wang
Publication date
01-11-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 11/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2484-x

Other articles of this Issue 11/2014

Tumor Biology 11/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine